Venn Life Sciences (VENN) Shares Up 16.1%
Venn Life Sciences Holdings PLC (LON:VENN) shares shot up 16.1% on Thursday . The company traded as high as GBX 1.85 ($0.02) and last traded at GBX 1.80 ($0.02). 1,832,648 shares traded hands during mid-day trading, an increase of 5,815% from the average session volume of 30,982 shares. The stock had previously closed at GBX 1.55 ($0.02).
In related news, insider Michael (Mike) Ryan sold 138,672 shares of the company’s stock in a transaction on Friday, December 21st. The stock was sold at an average price of GBX 2 ($0.03), for a total transaction of £2,773.44 ($3,623.99).
COPYRIGHT VIOLATION WARNING: This piece was reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this piece on another domain, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this piece can be read at https://theolympiareport.com/2019/01/24/venn-life-sciences-venn-shares-up-16-1.html.
Venn Life Sciences Company Profile (LON:VENN)
Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling.
Read More: What are Closed-End Mutual Funds?
Receive News & Ratings for Venn Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venn Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.